MARCAINE HYDROCHLORIDE W/ EPINEPHRINE Drug Patent Profile
✉ Email this page to a colleague
When do Marcaine Hydrochloride W/ Epinephrine patents expire, and when can generic versions of Marcaine Hydrochloride W/ Epinephrine launch?
Marcaine Hydrochloride W/ Epinephrine is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in MARCAINE HYDROCHLORIDE W/ EPINEPHRINE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MARCAINE HYDROCHLORIDE W/ EPINEPHRINE?
- What are the global sales for MARCAINE HYDROCHLORIDE W/ EPINEPHRINE?
- What is Average Wholesale Price for MARCAINE HYDROCHLORIDE W/ EPINEPHRINE?
Summary for MARCAINE HYDROCHLORIDE W/ EPINEPHRINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Clinical Trials: | 9 |
| DailyMed Link: | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE at DailyMed |
Recent Clinical Trials for MARCAINE HYDROCHLORIDE W/ EPINEPHRINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, San Francisco | Phase 3 |
| Carilion Clinic | Phase 3 |
| University of Wisconsin, Madison | Phase 4 |
See all MARCAINE HYDROCHLORIDE W/ EPINEPHRINE clinical trials
Pharmacology for MARCAINE HYDROCHLORIDE W/ EPINEPHRINE
| Drug Class | Amide Local Anesthetic Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
| Physiological Effect | Local Anesthesia |
